Assessing bioterrorism preparedness and response of rural veterinarians: experiences and training needs

Journal of Veterinary Medical Education
Chiehwen Ed HsuFrancisco Soto Mas

Abstract

Veterinarians play a unique role in emergency preparedness and response, and federal agencies and academic institutions therefore allocate considerable resources to provide training to enhance their readiness. However, the level of preparedness of veterinarians in many rural regions is yet to be improved. This article reports an assessment of the bioterrorism preparedness, specifically the experience and training needs, of rural veterinarians in North Texas. The study employed a cross-sectional design with a study population that included all veterinarians (N = 352) in the 37 counties within Texas Department of State Health Services Regions 2 and 3. Data on veterinarians practicing or residing in the target region were obtained from the Texas State Board of Veterinary Medical Examiners. The response rate was 35% (n = 121). Results indicate that chemical exposure was the condition most frequently seen and treated, followed by botulism and anthrax. The majority (80%) of respondents indicated that they had not previously participated in training related to bioterrorism preparedness, and many (41%) also indicated a willingness to participate in a state health department-initiated bioterrorism response plan. However, only 18% were c...Continue Reading

References

Sep 8, 2000·Journal of the American Veterinary Medical Association·D A AshfordD R Franz
Sep 8, 2000·Journal of Public Health Management and Practice : JPHMP·R J Gallo, D Campbell
Jul 11, 2002·Mayo Clinic Proceedings·Richard F Meyer, Stephen A Morse
Nov 8, 2002·Journal of the American Veterinary Medical Association·Donald L NoahHarvey R Crowder
Sep 13, 2003·Journal of Veterinary Medical Education·John BakerLeigh Sawyer
Dec 4, 2003·Journal of Veterinary Medical Education·Kent N HobletLawrence E Heider
Feb 21, 2004·Journal of Veterinary Medical Education·Marguerite PappaioanouStephen B Thacker
Apr 13, 2004·Journal of the American Veterinary Medical Association·Radford G Davis
Apr 13, 2004·Journal of the American Veterinary Medical Association·Radford G Davis
Jun 8, 2004·Journal of Veterinary Medical Education·Christa RiddleMegan Julian
Oct 12, 2005·Disaster Management & Response : DMR : an Official Publication of the Emergency Nurses Association·Chiehwen Ed HsuJames Zoretic
Sep 27, 2006·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Francisco Soto MasMichael Felán
Jan 16, 2007·Journal of Veterinary Medical Education·Alan R KatzPaul V Effler

❮ Previous
Next ❯

Citations

Jan 9, 2010·Public Health Nursing·Holly E JacobsonMisu Kim
Nov 22, 2014·Disaster Medicine and Public Health Preparedness·Joe S Smith, Gretchen A Kuldau
Dec 15, 2010·Disaster Medicine and Public Health Preparedness·June Beckman-MooreLindsay Ruland
Jun 14, 2019·Journal of Veterinary Medical Education·Carla L Huston, Kathleen L Ebers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science
Francisco Soto MasMichael Felán
Journal of Applied Animal Welfare Science : JAAWS
Shanna M DeckerThomas E Wittum
Disaster Management & Response : DMR : an Official Publication of the Emergency Nurses Association
Chiehwen Ed HsuJames Zoretic
Disaster Management & Response : DMR : an Official Publication of the Emergency Nurses Association
David Jarrett
© 2022 Meta ULC. All rights reserved